Detroit Lakes – October 01, 2026 -- Nexa has launched a creator marketplace that lets UGC creators and influencers keep 100% of their self-set rates, generating revenue instead through a brand-side platform fee.

Nexa connects brands and creators without subscription fees

Businesses can join Nexa for free, browse creator profiles with rates listed upfront, and secure promotional content deals directly without needing a subscription to access the marketplace.

Boston -- October 1, 2026 -- Wayfair Inc. (NYSE: W) will release third-quarter 2026 financial results before market open on November 4, 2026.

Wayfair schedules Q3 earnings call for November 4 at 8 a.m. ET

The company confirmed the quarter ended September 30, 2026, with a conference call set to review results the same morning the figures are published.

Morris Plains, N.J. – – October 01, 2026 -- Solstice Advanced Materials (NASDAQ: SOLS) will release its third-quarter 2026 financial results before market open on November 4, 2026, the specialty materials company confirmed.

Vancouver – October 01, 2026 -- Graphite One Inc. (TSXV: GPH) (OTCQX: GPHOF) has created a new advanced systems division targeting graphite applications in defense, space and national security markets, while disclosing roughly US$1.58 million in new investor-relations marketing contracts.

Boston – October 01, 2026 -- HoneyNaps, an AI-based sleep health technology company, has completed registration as a clinical research organization (CRO) with South Korea's National Enterprise for Clinical Trials (KoNECT), broadening its role in pharmaceutical and medical device trials worldwide.

Dublin – October 01, 2026 -- Neuromod Devices has appointed Joe Ghiz as Chief Commercial Officer and Shannon Basham as VP of Channel Development, moves aimed at accelerating global commercial expansion of its tinnitus treatment device, Lenire.

San Jose, Calif. – October 01, 2026 -- AppZen has launched ZenLM Plus, a family of finance-specialized large language models that outperformed seven frontier AI models on expense audit accuracy while cutting inference costs, the company announced.

Paramus, N.J. – October 01, 2026 -- NS Pharma, Inc. reported 5-year efficacy and safety data showing its investigational therapy brogidirsen maintained or improved motor function in Duchenne muscular dystrophy (DMD) patients amenable to exon 44 skipping, with zero treatment discontinuations across the study period.

Dallas – October 01, 2026 -- Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has accepted and granted priority review to Nanoscope Therapeutics' New Drug Application for MOGENRY (sonpiretigene isteparvovec, MCO-010), an optogenetic gene therapy for inherited retinal dystrophies (IRDs). If approved by the Ministry of Health, Labour and Welfare, MOGENRY would become the first disease-agnostic treatment available to IRD patients in Japan, a condition caused by mutations across more than 250 genes that leads to progressive photoreceptor loss and blindness.

Bethlehem – October 01, 2026 -- Kerry has opened its first manufacturing facility in Pennsylvania, a coffee extraction plant in Bethlehem that significantly expands the company's hot and cold brew capacity for North American customers.